Liz Lightstone
#172,735
Most Influential Person Now
Researcher
Liz Lightstone's AcademicInfluence.com Rankings
Liz Lightstoneengineering Degrees
Engineering
#8513
World Rank
#10068
Historical Rank
Electrical Engineering
#2664
World Rank
#2802
Historical Rank
Liz Lightstonecomputer-science Degrees
Computer Science
#11530
World Rank
#12227
Historical Rank
Computational Linguistics
#2917
World Rank
#2950
Historical Rank
Machine Learning
#5290
World Rank
#5357
Historical Rank
Artificial Intelligence
#5702
World Rank
#5785
Historical Rank
Download Badge
Engineering Computer Science
Liz Lightstone's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Liz Lightstone Influential?
(Suggest an Edit or Addition)According to Wikipedia, Elizabeth Beatrice Lightstone is a British physician and consultant who is a Professor of Nephrology at Imperial College London. Her research investigates disease in kidneys such as lupus nephritis, glomerular disease and chronic kidney disease . Lighthouse has also investigated healthcare inequalities.
Liz Lightstone's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (2012) (885)
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids (2013) (379)
- Genetic loci influencing kidney function and chronic kidney disease (2010) (266)
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine (2021) (252)
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults (2018) (226)
- Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021) (201)
- Goodpasture's disease (2001) (167)
- Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression (2021) (166)
- Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. (2002) (160)
- Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids. (2009) (155)
- European consensus statement on the terminology used in the management of lupus glomerulonephritis (2009) (137)
- Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis (2016) (125)
- Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. (2003) (118)
- Severe pre-eclampsia and hypertensive crises. (2013) (117)
- High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. (2020) (116)
- Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. (2016) (116)
- Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. (2013) (115)
- The Endogenous Pathway of MHC Class II Antigen Presentation (1996) (103)
- Urinary proteomic profiles distinguish between active and inactive lupus nephritis. (2006) (97)
- Pregnancy in chronic kidney disease and kidney transplantation. (2017) (96)
- Lupus nephritis management guidelines compared. (2016) (88)
- Clinical practice guideline on pregnancy and renal disease (2019) (83)
- In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. (2001) (78)
- Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection (2021) (68)
- Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis (2008) (67)
- Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. (1999) (67)
- Eculizumab as rescue therapy in severe resistant lupus nephritis (2015) (66)
- Tacrolimus is an effective treatment for lupus nephritis in pregnancy (2014) (62)
- Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. (1996) (59)
- Serum Creatinine in Pregnancy: A Systematic Review (2018) (58)
- High rates of tuberculosis in end-stage renal failure: the impact of international migration. (2002) (57)
- High incidence of end-stage renal disease in Indo-Asians in the UK. (1995) (57)
- In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. (1997) (53)
- Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers. (2020) (48)
- Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy (2017) (48)
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary. (2018) (47)
- Lupus nephritis: where are we now? (2010) (47)
- Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients (2021) (45)
- Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study. (2020) (43)
- Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab (2018) (41)
- Pre-pregnancy counseling for women with chronic kidney disease. (2012) (41)
- Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health. (2020) (40)
- The landscape after LUNAR: rituximab's crater-filled path. (2012) (36)
- Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome? (2017) (36)
- Lupus Nephritis and Pregnancy: Concerns and Management. (2017) (35)
- Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis (2014) (34)
- Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring (2020) (32)
- Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus (2021) (32)
- Can we manage lupus nephritis without chronic corticosteroids administration? (2017) (29)
- Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment. (2017) (28)
- Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis (2019) (28)
- The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes (2020) (27)
- Haplotype structure of TNFRSF5-TNFSF5 (CD40–CD40L) and association analysis in systemic lupus erythematosus (2005) (27)
- Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus (2021) (27)
- Minimising steroids in lupus nephritis – will B cell depletion pave the way? (2013) (27)
- Cholesterol emboli syndrome (2000) (26)
- Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial. (2020) (24)
- Updates in Diagnosis and Management of Preeclampsia in Women with CKD. (2020) (23)
- The clinical relevance of a repeat biopsy in lupus nephritis flares (2018) (22)
- Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD (2019) (21)
- Renoprotective strategies in lupus nephritis: beyond immunosuppression (2013) (20)
- Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era (2020) (20)
- Expression in vivo of CD45RA, CD45RB and CD44 on T cell receptor‐transgenic CD8+ T cells following immunization (1995) (20)
- Preventing renal disease: the ethnic challenge in the United Kingdom. (2003) (19)
- Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study. (2011) (18)
- CD45RA+ T cells: not simple virgins. (1993) (16)
- Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening. (2020) (16)
- Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series (2014) (16)
- The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post‐transcriptional regulation of the IFN‐γ/CXCL10 IP‐10 pathway (2015) (16)
- Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate. (2017) (16)
- Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines (2021) (16)
- A Multicenter Cohort Study of Histologic Findings and Long-Term Outcomes of Kidney Disease in Women Who Have Been Pregnant. (2017) (15)
- Problems in the physiology of class I and class II MHC molecules, and of CD45. (1989) (13)
- Pregnancy in pancreas–kidney transplant recipients: report of three cases and review of the literature (2010) (13)
- Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease. (2019) (13)
- Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients (2022) (12)
- Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients (2022) (12)
- Kidneys and women's health: key challenges and considerations (2018) (11)
- Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients—a potential biomarker of disease activity (2017) (11)
- Comparison of immunogenicity between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in a large haemodialysis population (2021) (11)
- Glomerular Disease in Women (2018) (10)
- Distal renal tubular acidosis in association with HIV infection and AIDS. (2006) (9)
- A multi-centre qualitative study exploring the experiences of UK South Asian and White Diabetic Patients referred for renal care (2012) (9)
- Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysis (2022) (9)
- OP0064 Joint EULAR/ERA-EDTA recommendations for the management of adult and pediatric lupus nephritis (2013) (9)
- Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply. (2018) (8)
- Life-threatening thrombosis 18 years after first presentation of primary antiphospholipid antibody syndrome. (2001) (8)
- Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. (2021) (7)
- Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program (2021) (7)
- Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial (2019) (7)
- Lesson for the clinical nephrologist: Kidney transplant, COVID-19 and pregnancy (2020) (6)
- SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19 (2020) (6)
- Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease (2021) (5)
- [42-OR]: Diagnostic accuracy of placental growth factor in women with chronic kidney disease or hypertension and suspected preeclampsia: A prospective cohort study (2015) (5)
- Anti-Müllerian hormone concentrations in women with chronic kidney disease (2019) (5)
- Sex and Gender in Glomerular Disease. (2022) (5)
- Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study (2022) (5)
- Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people? (2022) (5)
- Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments (2022) (4)
- SaO041PROSPECTIVE LONG TERM FOLLOW UP OF THE RITUXILUP STEROID SPARING REGIMEN IN LUPUS NEPHRITIS (2015) (4)
- Glomerular Disease and Pregnancy. (2020) (3)
- Renal Disease in Pregnancy: Postpartum follow-up of antenatally identified renal problems (2008) (3)
- COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry (2021) (3)
- Renal Disease in Pregnancy: Prepregnancy counselling and risk assessment: general overview (2008) (3)
- Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease. (2021) (3)
- Kidney disease and pregnancy (2015) (3)
- MO126CLINICAL AND BIOMARKER CHARACTERISTICS OF PATIENTS WITH C3G OR IC-MPGN ENROLLED IN TWO PHASE II STUDIES INVESTIGATING THE FACTOR D INHIBITOR DANICOPAN* (2021) (2)
- Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study (2019) (2)
- A Core Outcome Set for Trials in Glomerular Disease (2021) (2)
- Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies (2022) (2)
- The utility of a local multidisciplinary working group to oversee the establishment of rapidly evolving standards of care and to support trial recruitment during the COVID-19 pandemic. (2021) (2)
- A Focus Group Study of Self-Management in Patients With Glomerular Disease (2021) (2)
- THU0051 OFF-LICENCE USE OF ANAKINRA IN CRITICALLY ILL ADULTS WITH SUSPECTED HAEMOPHAGOCYTOSIS – A SINGLE CENTRE EXPERIENCE (2019) (2)
- Glomerular diseases in pregnancy: pragmatic recommendations for clinical management. (2022) (2)
- End-stage renal failure in Indo-Asians in the UK: a double whammy (2002) (2)
- Renal disease and pregnancy (2003) (2)
- Manifestations of lupus in the kidney and how to manage them (2017) (1)
- ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap (2016) (1)
- The impact of national chronic kidney disease management guidelines in the United Kingdom on referral patterns for South Asian and european patients with type 2 diabetes mellitus (2013) (1)
- Comparison of catheters or new arteriovenous fistulas for commencement of haemodialysis in pregnant women with chronic kidney disease: an international observational study (2022) (1)
- PregnancyRenal disease and pregnancy (2007) (1)
- A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case outcome (2007) (1)
- Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease (2021) (1)
- Kidney Disease in Ethnic Minority Populations of the United Kingdom (2005) (1)
- COVID-19 in patients with glomerular disease. (2021) (1)
- Anti-Müllerian hormone concentrations in women with chronic kidney disease (2020) (1)
- P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB (2016) (1)
- Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan (2022) (1)
- A complicated multisystem flare of systemic lupus erythematosus during pregnancy (2017) (1)
- Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipients (2022) (1)
- THE OBSTETRIC UNIT (2002) (0)
- Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation (2023) (0)
- P0247PREGNANCY IN WOMEN WITH NEPHROTIC-RANGE PROTEINURIA (2020) (0)
- PM.51 Challenges of Managing Pregnancy Complicated by Chronic Kidney Disease Stages 3–5: A Tertiary Centre’s Experience (2013) (0)
- POS-234 PREGNANCY-ASSOCIATED PROGRESSION OF CHRONIC KIDNEY DISEASE: DEVELOPMENT OF A CLINICAL PREDICTIVE TOOL (2021) (0)
- P514 - HLA-DM influences MHC class II peptide occupancy independently of the Ii chain (1996) (0)
- 17 Fertility and pregnancy issues in patients with lupus nephritis (2020) (0)
- P 41 Diagnostic biomarkers in women with CKD and superimposed pre-eclampsia (2017) (0)
- THE INFLUENCE OF AN INFLAMMATORY MILIEU ON ANTIGEN PRESENTATION - A POSSIBLE ROUTE TO AUTOIMMUNITY (1995) (0)
- OA20 Differences in management approaches for lupus nephritis within the UK (2023) (0)
- O71 - In the absence of Ii, MHC class II molecules display a distinct set of self peptides (1996) (0)
- Acute renal failure. (2001) (0)
- Renal Disease (2018) (0)
- Epidemiology and CKD - 1 (2009) (0)
- Preconceptional counseling for women with chronic kidney disease (2012) (0)
- SUN-019 IDENTIFYING OUTCOMES IMPORTANT TO PATIENTS WITH GLOMERULONEPHRITIS AND THEIR CAREGIVERS: A MULTINATIONAL NOMINAL GROUP STUDY (2019) (0)
- OP0044 WHOLE KIDNEY TRANSCRIPTOMIC ANALYSIS OF FORMALIN-FIXED PARAFFIN-EMBEDDED LUPUS NEPHRITIS KIDNEY BIOPSY TISSUE USING THE NANOSTRING NCOUNTER PLATFORM (2020) (0)
- 288. Obstetric and renal outcomes of pregnant women with chronic kidney disease (CKD) stages 3–5 (2018) (0)
- Regulatory T cell populations in goodpasture's disease and Alport's syndrome (2001) (0)
- The role of CD25+regulatory cells in restoring tolerance in autoimmune anti-GBM (Goodpasture's) disease. (2002) (0)
- BLISS-LN trial revisited: function matters. (2022) (0)
- 065 THE ASSOCIATION BETWEEN PARTICIPATION OF CHILDREN WITH CEREBRAL PALSY AND THE PHYSICAL, SOCIAL AND ATTITUDINAL ENVIRONMENT: A CROSS-SECTIONAL (2009) (0)
- Seasonal Relapsing Minimal Change Disease: A Novel Strategy for Avoiding Long-Term Immunosuppression (2012) (0)
- Lab methods, progression & risk factors for CKD - 2 (2009) (0)
- New Approaches to Treating LN (2014) (0)
- 02 Cyclophosphamide: what is its role in the treatment of lupus nephritis and the new treatment paradigm? (2022) (0)
- The kidney in rheumatological disorders (2020) (0)
- Prevalence of chronic kidney disease in South Asian and Black minorities: findings from a population based screening study in London, UK (2009) (0)
- Longevity of SARS-CoV-2 immune responses in reinfection (0)
- AB1308 Factors associated with the development of esrd in a recent large single centre cohort of patients with lupus nephritis (2018) (0)
- Palestine: the assault on health and other war crimes: Only way forward is to open up a dialogue (2004) (0)
- The patient with systemic lupus erythematosus (2015) (0)
- A new approach to de novo minimal change disease in pregnancy. (2021) (0)
- FP187TWENTY YEARS OF LUPUS NEPHRITIS MANAGEMENT - EVALUATION OF A MULTI ETHNIC PATIENT COHORT TO IDENTIFY FACTORS AFFECTING OUTCOME (2018) (0)
- 19 Lupus nephritis (2021) (0)
- AB0648 The effects of end stage renal failure on lupus disease activity (2013) (0)
- The spectrum of complement C9 staining in lupus nephritis (2017) (0)
- Glomerular endotheliosis in normal pregnancy and pre‐eclampsia (2004) (0)
- Update on scoring and providing evidence basis for assessing pathology in lupus nephritis. (2023) (0)
- Chapter 16 Systemic Lupus Erythematosus: Renal Involvement (2007) (0)
- Title: HYDROXICLOROQUINE BLOOD CONCENTRATION IN LUPUS NEPHRITIS: A DETERMINANT OF DISEASE OUTCOME? OR: ASSOCIATIONS BETWEEN BLOOD LEVELS OF HYDROXYCHLOROQUINE AND OUTCOME IN LUPUS NEPHRITIS (2017) (0)
- FP748PREGNANCY IN WOMEN REQUIRING DIALYSIS: A UK NATIONAL PROSPECTIVE COHORT STUDY (2015) (0)
- Quinine-dependent anti-glycoprotein antibodies causing thrombocytopenia and hemolytic uremic syndrome (HUS). (1997) (0)
- Immune gene expression and functional networks in distinct lupus nephritis classes (2022) (0)
- A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case progression (2007) (0)
- Contents Vol. 128, 2014 (2015) (0)
- Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY (2023) (0)
- PM.98 Maternal Renal Outcomes Following Pregnancy Complicated by Chronic Kidney Disease Stages 3–5 (2013) (0)
- Resident renal cell populations as antigen presenting cells for CD4+ T cells — A possible route to autoimmunity? (1997) (0)
- 1 Summary (2015) (0)
- The Renal Association Clinical Practice Guideline on Pregnancy аnd Renal Disease (2019) (0)
- Correspondence: End-stage renal failure in Indo-Asians (1995) (0)
- A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case presentation (2007) (0)
This paper list is powered by the following services:
Other Resources About Liz Lightstone
What Schools Are Affiliated With Liz Lightstone?
Liz Lightstone is affiliated with the following schools:
